Lung cancer risk assessment could be improved over existing guidelines by a four-protein biomarker blood test.
Browsing: early detection
A preliminary report has revealed that a blood test could be used as a tool to detect early-stage lung cancer in patients.
A study conducted out by Cancer Research UK has discovered that carrying out one-off PSA tests on asymptomatic men does not reduce prostate cancer deaths.
Recent research demonstrates that the ratio of abdominal fat to peripheral fat is a significant independent predictor of cancer.
Researchers have identified a panel of biomarkers in serum samples that could accurately detect the early stages of pancreatic cancer.
Researchers have developed an innovative technique to detect tumor DNA in blood with a greater degree of sensitivity and precision.
Skin cancer screening: recommendations for data-driven screening guidelines & a review of the US Preventative Services Task Force controversy
In this review article, over 50 leaders in the dermatology field critically assess current screening practice for melanoma in an effort to propose rational, risk-based, data-driven guidelines for skin cancer screening.
New perspective piece brings together the opinions of over 50 leading experts in the skin cancer field to assess controversies in current melanoma screening guidelines, as well as provide their own data-derived recommendations.
A test measuring levels of particular chemicals in the breath demonstrated encouraging results for the detection of stomach and esophageal cancer in a large patient trial.
A team of researchers have developed a digital polymerase chain reaction assay which may greatly improve the detection of cancer cells within blood.